missing translation for 'onlineSavingsMsg'
Learn More
Learn More
TLR2 Antibody, Novus Biologicals™
Rabbit Polyclonal Antibody has been used in 15 publications
Brand: Novus Biologicals NB100-56720SS
This item is not returnable.
View return policy
Description
TLR2 Polyclonal specifically detects TLR2 in Human, Mouse samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin.
Specifications
| TLR2 | |
| Polyclonal | |
| Unconjugated | |
| PBS with 0.05% Sodium Azide | |
| CD282 antigen, TIL4CD282, toll/interleukin 1 receptor-like 4, Toll/interleukin-1 receptor-like protein 4, toll-like receptor 2 | |
| Rabbit | |
| 89 kDa | |
| 0.025 mg | |
| Immunology, Innate Immunity, Signal Transduction, Toll Like Receptors | |
| 7097 | |
| Human, Mouse | |
| Purified |
| Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin) | |
| 1.0 mg/mL | |
| Western Blot 1-3 ug/ml, Flow Cytometry reported in scientific literature (PMID 31285077), Immunohistochemistry 1:10-1:500, Immunocytochemistry/Immunofluorescence reported in scientific literature (PMID 30618413), Immunoprecipitation reported in scientific literature (PMID 31383741), Immunohistochemistry-Paraffin 5 ug/ml | |
| O60603 | |
| TLR2 | |
| This antibody was developed against a mixture of synthetic peptides containing amino acids 180-196, 353-370, and 473-489 of human TLR2 (NP_003255). | |
| Protein G purified | |
| RUO | |
| Primary | |
| In transfected human TLR2 cell lysate, a 90 kDa band is observed. This has also been reported to work well in bronchial epithelial cells (UBH16E) and THP-1 cells. | |
| Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction